Neuland Laboratories hit a new high of Rs 11,093.15, as the stock rallied 18% on the BSE in Friday’s intra-day trade on the back of robust earnings for June 2024 quarter.

This Mukul Agrawal-owned stock crossed Rs 10,000-mark; up 725% in 2 years

Neuland Laboratories consolidated net profit rises 58.16% in the June 2024 quarter

Upcoming Result: Tata Motors, ITC, Sun Pharmaceutical Industries, Aditya Birla Capital, Adani Enterprises, Adani Ports and Special Economic Zone, Dabur India, Arvind Fashions, Escorts Kubota, Emami, Zomato, Kalyan Jewellers, Akzo Nobel India, Alkyl Amines Chemicals, Aptus Value Housing Finance, Cleans Science and Technology, Great Eastern Shipping, GHCL, Godrej Agrovet, G R Infraprojects, Indegene, Max Healthcare Institute, Neuland Laboratories, Orient Electric.

Stock Alert: Coal India, Bank of Baroda, Tata Steel, Sonata Software, Aster DM Healthcare

It has revised its target prices for Syngene International Limited and Neuland Laboratories Ltd.

Goldman Sachs Advises Shareholders To Sell And Buy Their Stakes In These Firms - News18

Brokerage Goldman Sachs has initiated a 'buy' rating on Syngene International Ltd and Neuland Laboratories Ltd and raised the target price by 20 percent to Rs 875 and by 46 percent to Rs 9,100 from the current market price. The brokerage house also initiated a 'sell' call on Laurus Labs Ltd with a target of Rs 350 a share, down 23 percent. Ekta Batra with the details. Listen in.

#pharmastocks #syngeneinternational #neulandlaboratories #lauruslabs #cnbctv18 #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday  

🔴CNBC TV18 LIVE TV: https://youtube.com/live/P857H4ej-MQ
SUBSCRIBE to our Channel: https://bit.ly/3nvEcxf
---------------------------------------------------------------------------------------------------------------------
👑 Check Out Top CNBC TV18 Playlist Videos: 

🔹CNBC TV18 Digital Podcast: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCUcGVQvYyDQ6VVHoo3ZDKJ

🔹Sounding Board: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBbB2dV2tyHdzx_k9EqvVEm 

🔹International Videos: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDZ-Dkz-VpCDqqmWThJ3YJw

🔹CNBC TV18 Market Cafe: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDANftdnJchuL-WPpSv5rmH

🔹CNBC TV18 Digital: https://www.youtube.com/playlist?list=PLjq9mRS1PfGDLhtM8FzErPcjmJRQ4I5cZ

🔹CNBC TV18 Weekend Special: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBHEa5NnoKuUsX5GwxEGuri

🔹CNBC TV18 Next-Gen: https://www.youtube.com/playlist?list=PLjq9mRS1PfGA6roe9q3J9fq_gBIDjX2w7

🔹Overdrive Show: https://www.youtube.com/playlist?list=PLjq9mRS1PfGCnSVjfbWfNCJLrv-CqfGmH

🔹Young Turks: https://www.youtube.com/playlist?list=PLjq9mRS1PfGBZaN1e38X2ZmevnU1e1NJs

🔹Startup Streets: https://www.youtube.com/playlist?list=PLjq9mRS1PfGD3CzrtMr_VJRbIly6sfyFI

------------------------------------------------------------------------------------
You can also connect with CNBC-TV18 News Online
Catch the latest news: https://bit.ly/2YbpXBM

Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/

Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/

You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/

Like us on Facebook: https://www.facebook.com/cnbctv18india/
Follow us on Twitter: https://twitter.com/CNBCTV18News
Follow us on Instagram: https://www.instagram.com/cnbctv18india/
Catch us on: Linkedin: https://in.linkedin.com/company/cnbc-tv18
n18oc_business

About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here.

Goldman Sachs Initiates Buy On Syngene, Neuland Labs & A Sell Rating On Laurus Labs | CNBC TV18

MSCI added 40 stocks to its Global Smallcap Index and removed 11. India has seen the maximum addition of stocks in the Global Smallcap Index within the Asia-Pacific region. Mrs Bector’s Food, Neuland Laboratories, and Patel Engineering are among 40 stocks that will be part of the MSCI Global Smallca…

MSCI index rejig may result in $1.4b inflows into stocks

Vijay Kedia has been holding on to a pharma stock Neuland Laboratories since December quarter of 2019. During this period, the stock has had a rollercoaster ride. Kedia bought the stock when it was in the Rs 300-400 range.

Vijay Kedia on why he sold 2 IT stocks; his temptation to sell shares & pharma scrip that tested his patience

IDBI Bank Ltd, Neuland Laboratories Ltd, Fairchem Organics Ltd and Confidence Petroleum India Ltd are among the other gainers in the BSE’s ‘A’ group today, 10 October 2022.

Garden Reach Shipbuilders & Engineers Ltd leads gainers in ‘A’ group

Jammu and Kashmir Bank Ltd, Neuland Laboratories Ltd, Indiabulls Housing Finance Ltd and Varun Beverages Ltd are among the other losers in the BSE’s ‘A’ group today, 27 September 2022.

Hester Biosciences Ltd leads losers in ‘A’ group

Neuland Laboratories said that Deepak Gupta, chief financial officer of the company, has informed the company that he would like to pursue career opportunities outside the company and as such has resigned from the services of the company.

Neuland Labs CFO Deepak Gupta resigns

Apar Industries Ltd, Swan Energy Ltd, Forbes & Company Ltd and Neuland Laboratories Ltd are among the other losers in the BSE’s ‘A’ group today, 05 September 2022.

Great Eastern Shipping Company Ltd leads losers in ‘A’ group

The creamy layer - amongst the top performing stocks

Performance

Seems to be overvalued vs the market average

Valuation

Financials growth has been moderate for a few years

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides custom manufacturing solutions (CMS) to develop and manufacture pharmaceutical ingredients and intermediates.